These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 18220622)

  • 21. An early diagnostic tool for diabetic peripheral neuropathy in rats.
    Kambiz S; van Neck JW; Cosgun SG; van Velzen MH; Janssen JA; Avazverdi N; Hovius SE; Walbeehm ET
    PLoS One; 2015; 10(5):e0126892. PubMed ID: 25984949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acupuncture Treatment of Diabetic Peripheral Neuropathy in an American Indian Community.
    Bailey A; Wingard D; Allison M; Summers P; Calac D
    J Acupunct Meridian Stud; 2017 Apr; 10(2):90-95. PubMed ID: 28483190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetes.
    Aubert CE; Michel PL; Gillery P; Jaisson S; Fonfrede M; Morel F; Hartemann A; Bourron O
    Diabetes Metab Res Rev; 2014 Nov; 30(8):679-85. PubMed ID: 24449227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.
    Cameron NE; Eaton SE; Cotter MA; Tesfaye S
    Diabetologia; 2001 Nov; 44(11):1973-88. PubMed ID: 11719828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetic autonomic neuropathy.
    Vinik AI; Maser RE; Mitchell BD; Freeman R
    Diabetes Care; 2003 May; 26(5):1553-79. PubMed ID: 12716821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Diabetic Cardiovascular Autonomic, Peripheral and Painful Neuropathy. Focus on the Treatment of Cardiovascular Autonomic Neuropathy with ACE Inhibitors.
    Didangelos T; Veves A
    Curr Vasc Pharmacol; 2020; 18(2):158-171. PubMed ID: 31109280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy.
    Yamagishi S; Imaizumi T
    Curr Pharm Des; 2005; 11(18):2279-99. PubMed ID: 16022668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic syndrome and peripheral neuropathy.
    Kazamel M; Stino AM; Smith AG
    Muscle Nerve; 2021 Mar; 63(3):285-293. PubMed ID: 33098165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention.
    Selvarajah D; Kar D; Khunti K; Davies MJ; Scott AR; Walker J; Tesfaye S
    Lancet Diabetes Endocrinol; 2019 Dec; 7(12):938-948. PubMed ID: 31624024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Painful neuropathy: Mechanisms.
    Lee-Kubli CA; Calcutt NA
    Handb Clin Neurol; 2014; 126():533-57. PubMed ID: 25410243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of glycemic variability on diabetic peripheral neuropathy.
    Jin HY; Lee KA; Park TS
    Endocrine; 2016 Sep; 53(3):643-8. PubMed ID: 27383181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diabetic somatic polyneuropathy. Pathogenesis, clinical manifestations and therapeutic concepts].
    Hilz MJ; Marthol H; Neundörfer B
    Fortschr Neurol Psychiatr; 2000 Jun; 68(6):278-88. PubMed ID: 10923253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging therapies for diabetic neuropathy: a clinical overview.
    Perkins BA; Bril V
    Curr Diabetes Rev; 2005 Aug; 1(3):271-80. PubMed ID: 18220603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study.
    Tesfaye S; Stevens LK; Stephenson JM; Fuller JH; Plater M; Ionescu-Tirgoviste C; Nuber A; Pozza G; Ward JD
    Diabetologia; 1996 Nov; 39(11):1377-84. PubMed ID: 8933008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy.
    Casellini CM; Barlow PM; Rice AL; Casey M; Simmons K; Pittenger G; Bastyr EJ; Wolka AM; Vinik AI
    Diabetes Care; 2007 Apr; 30(4):896-902. PubMed ID: 17392551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Association between neuropathy and peripheral vascular insufficiency in patients with diabetes mellitus type 2].
    Millán-Guerrero RO; Vásquez C; Isaís-Millán S; Trujillo-Hernández B; Caballero-Hoyos R
    Rev Invest Clin; 2011; 63(6):621-9. PubMed ID: 23650675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of diabetic neuropathy.
    Parry GJ
    Am J Med; 1999 Aug; 107(2B):27S-33S. PubMed ID: 10484042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variability in the clinical diagnosis of diabetic peripheral neuropathy.
    Chicharro-Luna E; Pomares-Gómez FJ; Ortega-Ávila AB; Coheña-Jiménez M; Gijon-Nogueron G
    Prim Care Diabetes; 2020 Feb; 14(1):53-60. PubMed ID: 31208891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral neuropathy is an early complication of type 2 diabetes in adolescence.
    Karabouta Z; Barnett S; Shield JP; Ryan FJ; Crowne EC
    Pediatr Diabetes; 2008 Apr; 9(2):110-4. PubMed ID: 18221439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complications of type 1 diabetes.
    Melendez-Ramirez LY; Richards RJ; Cefalu WT
    Endocrinol Metab Clin North Am; 2010 Sep; 39(3):625-40. PubMed ID: 20723824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.